Melanoma Clinical Trials at DFHCC
Melanoma Clinical Trials available at the Dana-Farber/Harvard Cancer Care Center (DF/HCC)
There are several clinical trials designed for treating patients with melanoma. Here are some of the trials that are offered through the Dana-Farber/Harvard Cancer Care Center.
Title: STA-4783 With Paclitaxel Versus Paclitaxel Alone in Melanoma
Phase: III
Modality: Chemotherapy, Immunotherapy
Sponsor Type: Private
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Title: SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma
Phase: III
Modality: Signal Transduction Inhibitor
Sponsor Type: Government
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Title: Imatinib in Patients With Mucosal or Acral/Lenginous Melanoma
Phase: II
Modality: Signal Transduction Inhibitor
Sponsor Type: Private
